Home-based cardiac rehabilitation for people with heart failure
Official title: Implementing a Home-based Cardiac Rehabilitation Program Among Rural Patients With Heart Failure
Run by University of Texas Southwestern Medical Center · NCT06349941 · Data updated 2026-11-12
This 12-week mobile app cardiac rehab program tests whether home-based rehab can improve outcomes for people with heart failure (EF ≥35%) who cannot attend center-based programs.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 332 (estimated) |
| Sponsor | University of Texas Southwestern Medical Center Academic / other |
| Locations | 2 sites (Dallas, Texas and 1 other locations) |
| Status | Recruiting |
| Started | August 15, 2025 |
| Main results expected | December 1, 2028 |
| Study ends | December 1, 2028 |
| Registry record updated | June 2, 2026 |
| Trial ID | NCT06349941 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with a recent hospitalization for acute heart failure, left ventricular ejection fraction ≥35%, who are unable to access center-based cardiac rehabilitation and have a smartphone and internet access are ideal candidates.
✕Probably not a fit
Patients with reduced ejection fraction below 35%, medical contraindications to exercise, life expectancy under six months, inability to use required technology, or those already enrolled in center-based cardiac rehab are unlikely to benefit from this program.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This Phase 3 randomized trial will enroll 332 patients with heart failure and left ventricular ejection fraction ≥35% who are not eligible for center-based rehabilitation and randomize them to a 12-week mHealth cardiac rehabilitation program using the Movn app plus accelerometer monitoring or to an attention control group. Randomization will be stratified by rural versus urban residence to compare implementation and effectiveness across geographic settings. The primary follow-up is six months and uses a composite endpoint of mortality, hospitalizations, and quality of life. The study will also measure implementation outcomes such as uptake, adherence, and feasibility in rural and urban participants.
Why it matters
Potential benefit: If successful, the program could expand access to cardiac rehabilitation, improve quality of life, and reduce hospitalizations for patients who cannot attend center-based rehab.
How similar studies have gone: Smaller home- and telehealth-based cardiac rehabilitation programs have shown improvements in exercise capacity and participation, but large randomized trials specifically in this heart failure population with rural versus urban stratification remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 years or older * History of hospitalization for acute heart failure within the last 12 months * Ability to participate in telemedicine visits * Access to smartphone or device capable of running the mHealth application * Willingness to participate in home-based cardiac rehabilitation program Exclusion Criteria: * Inability to participate in physical exercise or cardiac rehabilitation due to medical contraindications * Inability to provide informed consent * Lack of access to required technology (smartphone, internet connectivity) * Life expectancy less than 6 months * Inability to participate in telemedicine visits or remote monitoring * Current participation in another cardiac rehabilitation program
Where it's running
-
University of Texas Southwestern Medical Center
Dallas, Texas, United States Recruiting -
Baylor Scott and White Health System
Dallas, Texas, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
NT-proBNP–guided heart failure screening for people 65+ in rural China
This study tests whether using NT-proBNP blood tests to guide heart failure screening in adults 65 and older in rural China can find unrecognized heart problems more effectively than symptom-based screening.
-
Voice-based detection of heart failure deterioration using Noah Labs Vox
This study tests whether a voice-analysis app can flag worsening heart failure in adults by comparing its alerts to standard weight-based monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.